Inflammation represents the coordinated immune response to infection, trauma and injury.
When appropriately controlled, inflammation ensures competent host defence and prevents excessive damage of the affected tissue or organ structure.
In chronic inflammatory diseases, this process is disrupted and instead of offering protection, drives disease progression.
Area of interest
Cytokine immunology in chronic disease progression.
Principal members of staff
|Name||Area of interest|
|Professor Ernest Choy||Clinical rheumatology and biologic drug therapies|
|Dr Charlotte Rawlings||Clinical rheumatology|
|Professor Andrew Finlay||Infection|
|Professor Paul Martin||Cancer and wound healing|
|Dr John Ingram||Clinical dermatology|
|Professor Valerie O'Donnell||Lipidomics|
|Professor Peter Collins||Clinical haematology and clotting|
|Professor Paul Morgan||Complement biology, neuroimmunology|
|Professor Kathy Triantafilou|
|Dr Martha Triantafilou||Innate sensing mechanisms|
|Dr Timothy Hughes||Complement biology, cardiovascular disease|
|Professor Donald Fraser||Clinical nephrology and fibrosis|
|Dr Timothy Bowen||MicroRNA|
|Dr Mario Labeta||Innate sensing mechanisms|
|Dr Anne-Catherine Raby||Innate sensing mechanisms|
|Professor Aled Phillips||Clinical nephrology and renal scarring|
|Dr Robert Steadman||Clinical nephrology and renal scarring|
|Dr Soma Meran||Clinical nephrology and fibrosis|
|Professor Philip Taylor||Monocytic cell biology|
|Professor Anwen Williams||Experimental rheumatology|
|Dr Gareth Jones||Cytokine immunology in chronic disease progression|
|Dr Selinda Orr||Innate sensing mechanisms|
Our research creates benefits across health, society and the economy.